Live News Categoriesmarket

FARON (FARON) News

Follow FARON (FARON) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol FARON Asset market Sector Markets 90 days 1 Updated Nov 04, 2026, 02:27 PM UTC Open live news feed

M Faron Reports 85% Response Rate in Higher-Risk MDS Trial Faron reported an 85% response rate in a frontline higher-risk MDS trial of a bexmarilimab combination. EQUITY | Nov 04, 2026, 02:27 PM UTC